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Abstract
Pneumonia virus of mice (PVM; family Paramyxoviridae, subfamily Pneumovirinae) is a natural
respiratory pathogen of rodent species and an important new model for the study of severe viral
bronchiolitis and pneumonia. However, despite high virus titers typically detected in infected
mouse lung tissue in vivo, cell lines used routinely for virus propagation in vitro are not highly
susceptible to PVM infection. We have evaluated several rodent and primate cell lines for
susceptibility to PVM infection, and detected highest virus titers from infection of the mouse
monocyte-macrophage RAW 264.7 cell line. Additionally, virus replication in RAW 264.7 cells
induces the synthesis and secretion of proinflammatory cytokines relevant to respiratory virus
disease, including tumor necrosis factor-α (TNF-α), interferon-β (IFN-β), macrophage
inflammatory proteins 1α and 1β (MIP-1α and MIP-1β) and the functional homolog of human IL-8,
mouse macrophage inflammatory peptide-2 (MIP-2). Identification and characterization of a rodent
cell line that supports the replication of PVM and induces the synthesis of disease-related
proinflammatory mediators will facilitate studies of molecular mechanisms of viral pathogenesis
that will complement and expand on findings from mouse model systems.
Findings
Background
Pneumonia virus of mice (PVM) infection in mice was
originally described by Horsfall and colleagues [1,2], but
until relatively recently, the sole interest in this virus was
as a pathogen of laboratory rodent colonies [3-5]. Over
the past several years, we and others have built on Hors-
fall's early studies, and have developed and characterized
an in vivo model of severe respiratory virus infection using
PVM [reviewed in [6,7]]. Among our findings, we have
shown that a minimal, physiologically relevant inoculum
of PVM (typically <100 pfu) results in robust virus replica-
tion in lung tissue, accompanied by influx of granulocytes
in response to local production of specific proinflamma-
tory chemokines [8]. The pathophysiology of PVM bron-
chiolitis leading to pneumonia and acute respiratory
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distress syndrome (ARDS) is similar to that observed in
response to severe respiratory syncytial virus (hRSV) infec-
tion in human infants [9].
While PVM clearly replicates efficiently in mouse lung tis-
sue, the in vitro propagation of this pathogen is signifi-
cantly less straightforward. The primate BS-C-1 epithelial
cell line supports minimal rates of PVM replication in vitro
[10]. The BS-C-1 cell line has been used for traditional
plaque assays, but PVM-induced plaques develop slowly,
have relatively indistinct borders, and are difficult to eval-
uate quantitatively [see Figure 1A]. Furthermore, from an
evolutionary perspective, one would prefer to perform
molecular studies of virus pathogenesis in cells from a rel-
evant species, i.e...a rodent cell type or cell line. We have
demonstrated that PVM replicates in the mouse LA4 respi-
ratory epithelial cell line [11], but virus growth is similarly
slow, even at temperatures permissive for virus propaga-
tion in vitro.
In this work, we explore PVM replication in several inde-
pendent cell lines and identify the mouse macrophage
Infection of the mouse macrophage RAW 264.7 cell line with PVM Figure 1
Infection of the mouse macrophage RAW 264.7 cell line with PVM. (A) A plaque assay targeting the standard BS-C-
1 primate epithelial cell line (lower panel) compared to an uninfected control cell monolayer (upper panel). (B) Western blot 
of infected (+pvm) and control (-pvm) RAW 264.7 cell extracts (2 × 106 cell equivalents/lane) probed with rabbit polyclonal 
antisera directed against a specific 15-mer of the PVM N peptide. (C) Q-RT-PCR detecting PVM SH gene per microgram RNA 
[13] from triplicate cultures of infected (+pvm) and uninfected (-pvm) RAW 264.7 cells demonstrating ongoing PVM replication 
in infected cells; *p < 0.05 as indicated. (D) Q-RT-PCR detection of interferon-β in RNA from triplicate cultures of infected 
(+pvm, grey bars) and uninfected control (-pvm, white bars) cells, day 3 no infection normalized to 1.0 [13]; *p < 0.02 as indi-
cated. (E) Detection of proinflammatory cytokines (MIP-1α, MIP-1β, MIP-2 and TNF-α) in culture supernatants in response to 
infection, data shown with background levels subtracted; *p < 0.01 as indicated.Virology Journal 2007, 4:48 http://www.virologyj.com/content/4/1/48
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RAW 264.7 cells as supporting the highest rates of virus
replication. Furthermore, PVM infection of the RAW
264.7 cell line results in augmented synthesis of several
pro-inflammatory mediators that are directly related to
the pathogenesis of disease in vivo.
The study
The rodent L2, LA4, RAW 267.4, J774A.1, RLE and 3T3
and primate A549, BS-C-1, and HEp-2 cell lines obtained
from American Type Culture Collection (Manassas, VA)
were maintained in Iscove's Modified Dulbecco's medium
with 10% heat-inactivated fetal calf serum, 2 mM
glutamine and penicillin-streptomycin at 5% CO2 and
32°C (permissive for virus growth in culture) unless oth-
erwise indicated. Mouse-passaged PVM prepared as
described was stored in liquid nitrogen at ~106 pfu/ml
[12]. Virus replication in RAW 264.7 cells was determined
by both Q-RT-PCR detection of the virus SH gene [see ref-
erence [13]] for complete method] and by western blot
[14] probed with a 1:200 dilution of polyclonal anti-PVM
N peptide antibody prepared against sequence SQQLN-
IVDDTPDDDI encoding amino acids 379 – 393 of the
PVM N protein. Proinflammatory cytokines in culture
were evaluated by ELISA (R&D Systems, Minneapolis,
MN). Q-RT-PCR detection of interferon-β was via stand-
ard methods using primer – probe set Mm00439546_s1
(ABI, Columbia, MD) normalized as described [13] on
RNA prepared from infected and control uninfected cells
in culture (RNazol B, Friendship, TX).
Results and conclusion
The cell lines evaluated for the ability to support virus rep-
lication included rat epithelial L2 and RLE, mouse epithe-
lial LA4, mouse macrophage RAW 267.4 and J774A.1, and
primate epithelial A549, BS-C-1, and HEp-2. All were
inoculated with PVM on day 0 (MOI = 0.02, 104 pfu per 5
× 106 cells). On day 7, virus titer in the culture superna-
tants was determined by standard plaque assay [12].
Although pneumoviruses maintain strict host-pathogen
specificity in vivo, we determined that PVM replicated to a
limited extent in vitro (< 103 pfu/ml supernatant) in each
of the aforementioned cell lines. The mouse monocyte/
macrophage RAW 264.7 cell line (established from a
tumor induced by Abelson murine leukemia virus) gener-
ated the highest virus titers (104 pfu/ml) under culture
conditions described. Cells of the RAW 264.7 line also
support replication of other unrelated virus pathogens,
including murine hepatitis virus and Japanese encephali-
tis virus [15-17].
To evaluate the kinetics of virus replication and produc-
tion of proinflammatory mediators in the RAW 264.7 cell
line, cells at 50% confluence were inoculated with PVM
(MOI 0.1) on day 0 and harvested on days 2 – 5 thereafter.
RAW 264.7 is a semi-adherent cell line, and is not well-
suited for plaque assays. Here, virus replication was exam-
ined qualitatively on western blot of cellular homoge-
nates probed with PVM-specific antisera [Figure 1B]. Virus
was first detected in infected cultures on day 3 post-inoc-
ulation, and then in increasing amounts through day 5.
No immunoreactive PVM N protein was detected in unin-
fected control cultures.
Virus replication was also examined quantitatively by Q-
RT-PCR using the virus SH gene as a target sequence [13],
[Figure 1C]. PVM replication was readily detected in inoc-
ulated RAW 264.7 cells, reaching ~4 × 105 copies per
microgram total RNA on day 5 of infection. No copies of
the virus SH gene were detected in uninfected cells.
RAW 264.7 cells respond to infection with PVM by pro-
ducing a variety of proinflammatory mediators. Transcrip-
tion of interferon-β in response to virus infection was
detected by Q-RT-PCR [Figure 1D]. Cytokines MIP-2,
TNF-α, MIP-1α, and MIP-1β were detected in culture
supernatants by ELISA [Figure 1E]. Interestingly, MIP-1α
and MIP-2 are among the most prominent mediators
detected in BAL fluid of infected mice; MIP-1α levels cor-
relate directly with the severity of pneumovirus disease in
both PVM and hRSV infection [18,19]. In parallel to our
findings, hRSV replicates in the human monocytic THP-1
cell line [20], and several groups have provided evidence
consistent with hRSV and bovine RSV (bRSV) replication
in alveolar macrophages, although this point remains
controversial [21-25]. Furthermore, hRSV infection of the
human monocytic U937 cell line was associated with pro-
duction of the proinflammatory mediator, platelet-acti-
vating factor (PAF) [26].
In summary, PVM has recently emerged as a useful novel
model for the study respiratory disease in mice [7,27-30];
this has provided significant incentive toward identifying
tissue culture systems for virus propagation. The mouse
RAW 264.7 cell line supports efficient replication of PVM
in vitro and responds to infection by augmenting produc-
tion of cytokines implicated in the pathogenesis of respi-
ratory disease. Use of this ex vivo model of PVM infection
will permit further study of biological responses associ-
ated with virus infection and the cellular and molecular
level.
Abbreviations
PVM pneumonia virus of mice
IFN interferon
MIP macrophage inflammatory peptide
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RSV respiratory syncytial virus
ARDS acute respiratory distress syndrome
Q-RT-PCR quantitative reverse-transcriptase polymerase
chain reaction
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